|
|
|
|
|
Katyayani Tatiparti, Mohd Ahmar Rauf, Samaresh Sau and Arun K. Iyer
Triple-negative breast cancer (TNBC) is amongst the most challenging tumor subtypes because it presents itself without the estrogen, progesterone, and HER2 receptors. Hence, assessing new markers is an essential requirement for enhancing its targeted tre...
ver más
|
|
|
|
|
|
|
|
|
|
|
Claudio Luparello, Debora Ragona, Dalia Maria Lucia Asaro, Valentina Lazzara, Federica Affranchi, Vincenzo Arizza and Mirella Vazzana
Triple-negative breast cancer (TNBC) is a highly malignant tumor histotype which lacks effective targeted therapies, thereby being considered as the most aggressive form of breast carcinoma. To identify novel compounds which could counteract TNBC cell gr...
ver más
|
|
|
|
|
|
|
|
|
|
|
Anis Ahmad, Tulasigeri M. Totiger, Ana Paula Benaduce, Brian Marples and Ivaylo Bodganov Mihaylov
Triple-negative breast cancer (TNBC), which is a type of invasive breast cancer, is characterized by severe disease progression, poor prognosis, high recurrence rate, and short survival. We sought to gain new insight into TNBC by applying computed tomogr...
ver más
|
|
|
|
|
|
|
|
|
|
|
Sandra Milena Sanabria Barrera, Lissette Carolina Sánchez Aranguren, Micael Hardy, Olivier Ouari, Marcos López Casillas
Pág. 8 - 9
El Cáncer Hepático o Carcinoma Hepatocelular (HCC) y el Cáncer de Seno Triple Negativo (por sus siglas en inglés TNBC, Triple Negative Breast Cancer), son problemas de salud pública en el mundo, por su difícil tratamiento y alta resistencia a la quimiote...
ver más
|
|
|
|
|
|